Top Markets
Coin of the day
AegirBio AB (publ) AegirBio AB (publ)

AegirBio AB (publ)

AEGIR
Rangering i aksjer #38668
AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden.... AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden. The company specializes in developing and commercializing tests primarily aimed at monitoring the dosage of biological drugs. Their efforts are concentrated on therapeutic drug monitoring for biologic therapies across various conditions, including multiple sclerosis, different types of cancer, and autoimmune diseases. Among their offerings are moNATor, a pioneering laboratory test designed for dose monitoring in multiple sclerosis for both medical professionals and patients, and Viraspec, a saliva-based test kit for COVID-19 detection.
Aksjekurs
$0.04057595
Sist synkronisert: 2024-08-05
Markedsverdi
$863.62K
Endring (1 dag)
0.31%
Endring (1 år)
0.00%
Land
SE
Handel AegirBio AB (publ) (AEGIR)

Kategori

P/B-forhold for AegirBio AB (publ) (AEGIR)
P/B-forhold per August 2026 TTM: -7.38
Ifølge AegirBio AB (publ) sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) -7.38. Ved slutten av 2022 hadde selskapet et P/B-forhold på 0.97.
P/B-historikk for AegirBio AB (publ) fra 2019 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
2026 (TTM) -7.38 -63.41%
2023 -20.17 -2,180.89%
2022 0.97 -61.61%
2021 2.53 -61.19%
2020 6.51 -92.78%
2019 90.12 0.00%
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.8941 -193.42%
US
1.9293 -126.14%
FR
- -
JP
1.926 -126.10%
US
- -
CH